TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
- PMID: 30165166
- DOI: 10.1016/j.jaad.2018.08.032
TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
Abstract
Background: Telomerase reverse transcriptase gene (TERT) promoter (TERTp) mutations have been reported as potential predictors of poor prognosis in several cancers, but the prognostic value of TERTp mutations for cutaneous squamous cell carcinoma (cSCC) has not been determined.
Objective: To evaluate the frequency of TERTp mutations and correlate it with clinicopathologic features and patient outcome.
Methods: We performed genetic profiling of TERTp mutations in a retrospective series of cSCCs. The predictive value of TERTp mutations and clinicopathologic parameters were assessed by using logistic regression models.
Results: A total of 152 cSCCs from 122 patients were analyzed for TERTp mutations; the mutation rate was 31.6% (48 of 152), and it was higher in invasive cSCC (42 of 121 [34.7%]) than in in situ cSCC (6 of 31 [19.4%]). Age older than 75 years (odds ratio [OR], 14.84; P = .013] and TERTp mutation (OR, 8.11; P = .002) were independent predictors of local recurrence. TERTp mutation (OR, 15.89; P = .022) was independently associated with higher risk of lymph node metastasis.
Limitations: The restricted number of metastatic cases.
Conclusion: TERTp mutations may prove to be a molecular biomarker with prognostic significance in invasive cSCC, but larger studies are needed.
Keywords: TERT; TERT promoter mutation; biomarker; cutaneous squamous cell carcinoma; metastases; outcome; prognosis; prognostic biomarker; recurrence; squamous cell carcinoma.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Promoting TERT promoter mutations for prognostication in cutaneous oncology.J Am Acad Dermatol. 2019 Mar;80(3):606-607. doi: 10.1016/j.jaad.2018.12.039. Epub 2018 Dec 22. J Am Acad Dermatol. 2019. PMID: 30584893 No abstract available.
Similar articles
-
Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas.Genes (Basel). 2020 Jul 6;11(7):751. doi: 10.3390/genes11070751. Genes (Basel). 2020. PMID: 32640663 Free PMC article.
-
Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.Int J Mol Sci. 2019 Mar 16;20(6):1333. doi: 10.3390/ijms20061333. Int J Mol Sci. 2019. PMID: 30884806 Free PMC article. Review.
-
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.J Neurooncol. 2016 Feb;126(3):441-6. doi: 10.1007/s11060-015-1999-3. Epub 2015 Nov 25. J Neurooncol. 2016. PMID: 26608520
-
Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.Pathol Res Pract. 2018 Jun;214(6):881-888. doi: 10.1016/j.prp.2018.04.002. Epub 2018 Apr 5. Pathol Res Pract. 2018. PMID: 29650441
-
The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis.J Neurooncol. 2019 Mar;142(1):1-10. doi: 10.1007/s11060-018-03067-x. Epub 2018 Dec 1. J Neurooncol. 2019. PMID: 30506498
Cited by
-
The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts.Cancers (Basel). 2022 Jan 13;14(2):377. doi: 10.3390/cancers14020377. Cancers (Basel). 2022. PMID: 35053539 Free PMC article. Review.
-
Association of ADC of hyperintense lesions on FLAIR images with TERT promoter mutation status in glioblastoma IDH wild type.Surg Neurol Int. 2024 Mar 29;15:108. doi: 10.25259/SNI_63_2024. eCollection 2024. Surg Neurol Int. 2024. PMID: 38628517 Free PMC article.
-
Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review.Cancers (Basel). 2023 Mar 17;15(6):1832. doi: 10.3390/cancers15061832. Cancers (Basel). 2023. PMID: 36980718 Free PMC article. Review.
-
TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features.Sci Rep. 2021 May 17;11(1):10395. doi: 10.1038/s41598-021-89906-w. Sci Rep. 2021. PMID: 34001963 Free PMC article.
-
AXIN2 and SNAIL expression predict the risk of recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery.Oncol Lett. 2020 Mar;19(3):2133-2140. doi: 10.3892/ol.2020.11324. Epub 2020 Jan 21. Oncol Lett. 2020. PMID: 32194711 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical